RPRX
Royalty Pharma plc - Ordinary Shares - Class A

7,301
Mkt Cap
$26.07B
Volume
5.41M
52W High
$45.91
52W Low
$29.66
PE Ratio
25.38
RPRX Fundamentals
Price
$45.19
Prev Close
$44.80
Open
$44.80
50D MA
$40.42
Beta
0.34
Avg. Volume
3.85M
EPS (Annual)
$1.78
P/B
2.99
Rev/Employee
$23.78M
$33,378.10
Loading...
Loading...
Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
100

Frequently Asked Questions

What is Market Cap of Royalty Pharma plc - Ordinary Shares - Class A?
What is the 52-week high for Royalty Pharma plc - Ordinary Shares - Class A?
What is the 52-week low for Royalty Pharma plc - Ordinary Shares - Class A?
What is Royalty Pharma plc - Ordinary Shares - Class A stock price today?
What was Royalty Pharma plc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Royalty Pharma plc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Royalty Pharma plc - Ordinary Shares - Class A?
What is the 50-day moving average of Royalty Pharma plc - Ordinary Shares - Class A?
How many employees does Royalty Pharma plc - Ordinary Shares - Class A have?

Latest RPRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.